BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Financial Results | 24 June 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

No summary available

About BALAXI PHARMACEUTICALS LIMITED (BALAXI)

Healthcare · Pharmaceuticals · Listed on NSE

ROE: 1.1% ROCE: 3.6%

View full BALAXI stock details →

📡 Get AI alerts when BALAXI files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BALAXI — Free

📊 More BALAXI filings

See all BALAXI filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BALAXI files new disclosures

Track BALAXI filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track BALAXI — Free

Free account · 2 AI queries/day